Anticancer Activity of Cisplatin and Related Complexes

This publication has 115 references indexed in Scilit:

• NMR Solution Structure of a DNA Dodecamer Duplex Containing a cis-Diammineplatinum(II) d(GpG) Intrastrand Cross-Link, the Major Adduct of the Anticancer Drug Cisplatin
  Biochemistry, 1998
• A mechanism-based, solution-phase method for screening combinatorial mixtures of potential platinum anticancer drugs
  JBIC Journal of Biological Inorganic Chemistry, 1998
• Structural Transitions of a GG‐Platinated DNA Duplex Induced by pH, Temperature and Box A of High‐Mobility‐Group Protein 1
  European Journal of Biochemistry, 1997
• The acidic tail of the high mobility group protein HMG-D modulates the structural selectivity of DNA binding 1 1 Edited by M. Yaniv
  Journal of Molecular Biology, 1997
• The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast
  Mutation Research/DNA Repair, 1996
• Binding of Ixr1, a Yeast HMG-Domain Protein, to Cisplatin−DNA Adducts in Vitro and in Vivo
  Biochemistry, 1996
• A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif
  Nature, 1990
• Binding of cis- and trans-diamminedichloroplatinum(II) to deoxyribonucleic acid exposes nucleosides as measured immunochemically with anti-nucleoside antibodies
  Biochemistry, 1986
• Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation
  Biochemistry, 1985
• Kinetic analysis of the in vitro binding of radioactive cis- and trans-dichlorodiammineplatinum(II) to DNA
  Chemico-Biological Interactions, 1980